Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,043 | -24,930 | -8,082 | -37,543 | -32,790 |
| Depreciation Amortization | -1,021 | -575 | -111 | 248 | 182 |
| Accounts payable and accrued liabilities | -1,151 | -1,084 | -1,058 | 1,204 | 114 |
| Other Working Capital | 3,048 | -1,273 | -3,386 | 861 | -5,055 |
| Other Operating Activity | 7,995 | 4,664 | 2,665 | 4,903 | 6,723 |
| Operating Cash Flow | $-31,172 | $-23,197 | $-9,973 | $-30,326 | $-30,827 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,352 | -48,615 | -30,377 | 30,000 | 30,000 |
| Investing Cash Flow | $-43,352 | $-48,615 | $-30,377 | $30,000 | $30,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38 | 18 | 18 | 305 | 275 |
| Other Financing Activity | -217 | 0 | 0 | -1,575 | -533 |
| Financing Cash Flow | $-179 | $18 | $18 | $-1,270 | $-258 |
| Beginning Cash Position | 142,823 | 142,823 | 142,823 | 144,419 | 144,419 |
| End Cash Position | 68,120 | 71,030 | 102,492 | 142,823 | 143,335 |
| Net Cash Flow | $-74,703 | $-71,793 | $-40,331 | $-1,596 | $-1,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,172 | -23,197 | -9,973 | -30,326 | -30,827 |
| Free Cash Flow | -31,172 | -23,197 | -9,973 | -30,326 | -30,827 |